EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases

Mathias Lazarevic Lindblad iD, Elin Pålsson, Vladimir Lazarevic iD, Leila Naddi iD, Ola Borgquist iD, Lars Nilsson, Maria Adrian iD, Björn P Bark iD, Thomas Kander iD

European Journal of Haematology · 2026-12 · 117 (6) · 1531-1540

DOI: 10.1111/ejh.70287 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Haematology, online erschienen am 07.08.2026. Verfasst von Mathias Lazarevic Lindblad und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Platelet Transfusion, Catheterization, Central Venous, Hematologic Diseases. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Government Grant for Clinical Research Within the Swedish National Health Service, Regional Research Grant from Region Skåne, Sweden, Landstingens Ömsesidiga Försäkringsbolag.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation.

Methods

We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion performed in adult patients with haematological diseases between 2013 and 2026 at the Department of Haematology, Skåne University Hospital, Lund, Sweden. In March 2023, the recommended platelet transfusion threshold before CVC insertion was lowered from < 50 × 10 9 /L to < 10 × 10 9 /L. The primary outcome was the proportion of grade 3–4 bleeding events. Secondary outcomes included the proportion of grade 2 bleeding events and transfusion practices.

Results

A total of 992 patients were included (715 before and 277 after implementation). Grade 3–4 bleeding events occurred in 14/715 procedures before implementation and in none of the 277 insertions after implementation (absolute risk difference −2.0%, 95% CI: −3.3 to −0.4; p = 0.014). Grade 2 bleeding events were unchanged (8.5% vs. 6.5%, absolute risk difference −2.0%, 95% CI: −5.2 to 2.0; p = 0.289). Preprocedural platelet transfusions decreased substantially (30% vs. 6.5%; p < 0.001).

Conclusions

Lowering the platelet transfusion threshold to < 10 × 10 9 /L was not associated with increased bleeding complications and reduced platelet transfusion use. These findings support a more restrictive preprocedural transfusion strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet TransfusionCatheterization, Central VenousHematologic DiseasesHumansFemaleMaleMiddle AgedAgedHemorrhageAdultThrombocytopeniaAged, 80 and over

Stichwörter der Autor:innen

bleedingcentral venous catheterisationhaematological diseasesplatelet transfusionthrombocytopeniavascular access

Autor:innen und Institutionen

  • Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.
  • Department of Haematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Department of Cardiothoracic Surgery Anaesthesia and Intensive Care, Skåne University Hospital, Lund, Sweden.
  • Department of Anaesthesia and Perfusion, The Prince Charles Hospital, Brisbane, Queensland, Australia.

ORCID-Profile: Mathias Lazarevic Lindblad, Vladimir Lazarevic, Leila Naddi, Ola Borgquist, Maria Adrian, Björn P Bark, Thomas Kander

Förderung

  • Swedish Government Grant for Clinical Research Within the Swedish National Health Service
  • Regional Research Grant from Region Skåne, Sweden
  • Landstingens Ömsesidiga Försäkringsbolag
  • Swedish Society of Medicine
  • Svenska Läkaresällskapet

Zitieren

APA

Lazarevic Lindblad, M., Pålsson, E., Lazarevic, V., Naddi, L., Borgquist, O., Nilsson, L., Adrian, M., Bark, B. P., & Kander, T. (2026). Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases. European Journal of Haematology, 117(6), 1531-1540. https://doi.org/10.1111/ejh.70287

Vancouver

Lazarevic Lindblad M, Pålsson E, Lazarevic V, Naddi L, Borgquist O, Nilsson L, et al. Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases. European Journal of Haematology. 2026;117(6):1531-1540. doi:10.1111/ejh.70287

BibTeX
@article{LazarevicLindblad2026,
  author = {Lazarevic Lindblad, Mathias and Pålsson, Elin and Lazarevic, Vladimir and Naddi, Leila and Borgquist, Ola and Nilsson, Lars and Adrian, Maria and Bark, Björn P and Kander, Thomas},
  title = {Safety of Lowering the Platelet Transfusion Threshold Before Central Venous Catheterisation in Patients With Haematological Diseases},
  journal = {European Journal of Haematology},
  year = {2026},
  volume = {117},
  number = {6},
  pages = {1531--1540},
  doi = {10.1111/ejh.70287}
}
Kostenlos starten →